Skip to content

Early gallbladder removal or initial non-operative treatment for an infected gallbladder that has been inflamed during a week or more.

Early Laparoscopic cholEcystectomy versus Conservative TReatment beyond the 7-day barrIer of Cholecystitis. A multicentre randomised controlled trial. - The ELECTRIC trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58101
Enrollment
110
Registered
2025-07-01
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholecystitis

Interventions

Group A: same admission laparoscopic cholecystectomy by or supervised by a laparoscopic surgeon with affinity for cholecystitis or complex galbladder disease.&nbsp
Group B: non-surgical treatment, which might consist of analgesia, intravenous fluids, antibiotics, or gallbladder drainage. Cholecystectomy a froid to the discretion of the treating physician.

Sponsors

St. Antonius Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a definitive diagnosis of calculous cholecystitis following the Tokyo Guideline Criteria:Symptoms of cholecystitis persisting for 7 days or longer at time of diagnosisAge =18 years

Exclusion criteria

Exclusion criteria: Inability to comprehend the study (preventing informed consent).Concomitant pancreatitis.Gallbladder fistula.Active locoregional malignancy.Pregnancy.Absolute contraindications for general anaesthesia (e.g. hemodynamic instability), as determined by the attending anaesthesiologist.

Design outcomes

Primary

MeasureTime frame
Primary endpoint: overall morbidity (composite outcome of: intra -or postoperative complications, failure of conservative treatment and readmissions or emergency consultations) within one-year follow-up.  

Secondary

MeasureTime frame
Secondary endpoints: all individual components of the composite endpoint, total days admitted to the hospital, all complications graded Clavien-Dindo grade =22, recurrent biliary events, bile duct injury, patient satisfaction, quality of life, re-admissions or emergency consultations, duration of surgery, conversion-rate and costs. 

Countries

Netherlands

Contacts

Public ContactTJ Weijs

St. Antonius Ziekenhuis

t.weijs@antoniusziekenhuis.nl0612093752

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026